Haemonetics Additive Solution Formula 3 (AS-3) (Haemonetics Corporation)
Welcome to the PulseAid listing for the Haemonetics Additive Solution Formula 3 (AS-3) drug offered from Haemonetics Corporation. This Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Haemonetics Corporation |
NON-PROPRIETARY NAME: | CITRIC ACID MONOHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, SODIUM CHLORIDE, ADENINE, ANHYDROUS DEXTROSE, TRISODIUM CITRATE DIHYDRATE |
SUBSTANCE NAME: | CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM CHLORIDE; ADENINE; ANHYDROUS DEXTROSE; TRISODIUM CITRATE DIHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA] |
ROUTE: | EXTRACORPOREAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2013-01-10 |
END MARKETING DATE: | 0000-00-00 |
Haemonetics Additive Solution Formula 3 (AS-3) HUMAN PRESCRIPTION DRUG Details:
Item Description | Haemonetics Additive Solution Formula 3 (AS-3) from Haemonetics Corporation |
LABELER NAME: | Haemonetics Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 4.2; 27.6; 41; 3; 100; 58.8(mg/mL; mg/mL; mg/mL; mg/mL; mg/mL; mg/mL) |
START MARKETING DATE: | 2013-01-10 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57826-460_5ae72cea-f76f-4988-aaf3-a17aea22b69f |
PRODUCT NDC: | 57826-460 |
APPLICATION NUMBER: | BN000127 |
Other CITRIC ACID MONOHYDRATE; SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE; SODIUM CHLORIDE; ADENINE; ANHYDROUS DEXTROSE; TRISODIUM CITRATE DIHYDRATE Pharmaceutical Manufacturers / Labelers: